Calcipotriene 0.005%–Betamethasone Dipropionate 0.064% Ointment Versus Topical Suspension in the Treatment of Plaque Psoriasis: A Randomized Pilot Study of Patient PreferenceDecember 15, 2014Psoriasis
Most Common Dermatologic Conditions Encountered by Dermatologists and NondermatologistsDecember 10, 2014Psoriasis
Calcipotriene–Betamethasone Dipropionate Topical Suspension in the Management of Psoriasis: A Status Report on Available Data With an Overview of Practical Clinical Application September 10, 2014Psoriasis
Palmoplantar Pustular Psoriasis Following Initiation of a Beta-blocker: Disease Control With Low-Dose MethotrexateSeptember 8, 2014Psoriasis
